NDAORALTABLET
Approved
May 1974
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 16h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HYDROPRES 25 is a fixed-dose combination tablet containing hydrochlorothiazide (a thiazide diuretic) and reserpine (an antihypertensive alkaloid) approved in 1974 for the treatment of hypertension. This oral antihypertensive works through dual mechanisms: thiazide-induced sodium and water excretion combined with reserpine's sympathetic nervous system depletion. The product represents a legacy antihypertensive from the pre-ACE inhibitor era.
LOE Approaching
With LOE approaching and minimal linked job openings, this product likely operates as a mature, low-margin line with a skeleton commercial team focused on maintenance rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
HYDROPRES 25 offers minimal career development opportunity given zero linked job openings and approaching LOE status. Positions associated with this product are typically maintenance-focused, serving existing patient populations with limited growth trajectory or skill-building potential.
Regulatory Affairs SpecialistField Sales Representative
Worked on HYDROPRES 25 at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.